✦ LIBER ✦

Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody

✍ Scribed by Omidfar, Kobra; Amjad Zanjani, Fatemeh Sadat; Hagh, Arghavan Golbaz; Azizi, Maedeh Darziani; Rasouli, Seyed Javad; Kashanian, Susan

Book ID: 121600954
Publisher: Springer
Year: 2013
Tongue: English
Weight: 386 KB
Volume: 40
Category: Article
ISSN: 0301-4851
DOI: 10.1007/s11033-013-2790-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficient inhibition of EGFR signalling

Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

✍ Rob C. Roovers; Toon Laeremans; Lieven Huang; Severine De Taeye; Arie J. Verklei 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 542 KB

152 CETUXIMAB IS AN EFFICIENT CARRIER OF

152 CETUXIMAB IS AN EFFICIENT CARRIER OF RADIONUCLIDES TO TARGET EGFR-EXPRESSING TUMOR CELLS

✍ N. Cordes; I. Eke; C. Förster; M. Ingargiola; L. Kunz-Schughart; R. Runge; J. Ko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Effective suppression of breast tumor gr

Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody

✍ Shuhui Wang; Changchun Chen; Yanchun Meng; Shi Hu; Lei Zheng; Jinjing Song; Dape 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 684 KB

Growth inhibition of an established A431

Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV

✍ Ho, D T; Wykoff-Clary, S; Gross, C S; Schneider, D; Jin, F; Kretschmer, P J; Her 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 392 KB

Efficient growth inhibition of HPV 16 E6

Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73β

✍ Das, Sanjeev; El-Deiry, Wafik S; Somasundaram, Kumaravel 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant